Table 5.

Proportion of subjects with values higher than the cut-off for the IR, insulin sensitivity, and beta-cell function indices

Variable	Cut-off value	Control group (n = 75)	MetS group (n = 75)	P
HOMA-IR	≥ 2.86	34 (45.3)	70 (93.3)	0.001
HOMA2-IR	≥ 1.69	27 (36)	60 (80)	0.001
HOMA-AD	≥ 6.26	12 (16)	52 (69.3)	0.001
HOMA-TG	≥ 0.72	15 (20)	43 (57.3)	0.001
TyG index	≥ 9.88	9 (12)	57 (76)	0.001
FIGR	≥ 2.41	12 (16)	35 (46.7)	0.001
FIRI	≥ 2.96	22 (29.3)	65 (86.7)	0.001
HOMA-1%S	≤ 28.2	18 (24)	59 (78.7)	0.001
HOMA-2%S	≤ 53.9	19 (25.3)	52 (69.3)	0.001
QUICKI	≤ 0.32	29 (38.7)	70 (93.3)	0.001
Bennet index	≤ 1.2	19 (25.3)	67 (89.3)	0.001
McAuley index	≤ 6.05	11 (14.7)	46 (61.3)	0.001
Raynaud index	≤ 3.10	28 (37.3)	57 (76)	0.001
1/Insulin	≤ 0.08	37 (49.3)	65 (86.7)	0.001
GI ratio	≤ 7.45	11 (14.7)	36 (48)	0.001
FISI	≤ 6.96	17 (22.7)	60 (80)	0.001
SPISE	≤ 3.79	5 (6.7)	43 (57.3)	0.001
HOMA-1%B	≤ 94.74	7 (9.3)	56 (74.7)	0.001
HOMA-2%B	≤ 87.12	6 (8)	57 (76)	0.001

Values are presented as number (%).

IR, insulin resistance; MetS, metabolic syndrome; HOMA, homeostatic model assessment; AD, adiponectin; TG, triglycerides; TyG, triglyceride-glucose; FIGR, fasting insulin to glucose ratio; FIRI, fasting insulin resistance; %S, insulin sensitivity; QUICKI, quantitative insulin sensitivity check index; 1/Insulin, reciprocal insulin; GI, glucose to insulin; FISI, fasting insulin sensitivity index; SPISE, single-point insulin sensitivity estimator; %B, beta-cell function.